Carregant...
Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools
BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain tumor. Currently, the suggested line of action is the surgical resection followed by radiotherapy and treatment with the adjuvant temozolomide, a DNA alkylating agent. However, the ability of tumor cells to deeply infiltrate the sur...
Guardat en:
| Publicat a: | Cancer Rep (Hoboken) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941428/ https://ncbi.nlm.nih.gov/pubmed/32729241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1220 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|